Aurobindo Pharma confirms buyback completion and hits 52-week high
after close1 source ↓written by the desknot a recommendation
- as part
- 14 May 2026
- part
- ₹800 crore buyback
- ₹1,475 per share
- reached a new
- 52-week high of ₹1,530
Aurobindo Pharma Ltd confirmed the extinguishment of 5,423,728 equity shares on 14 May 2026 as part of its ₹800 crore buyback at ₹1,475 per share. The stock recently reached a new 52-week high of ₹1,530, attracting significant investor interest. This share reduction may enhance earnings per share metrics over time.
Not investment advice. For informational purposes only.